Drug Shortage Report for AURO-RISEDRONATE
| Report ID | 87274 |
| Drug Identification Number | 02406306 |
| Brand name | AURO-RISEDRONATE |
| Common or Proper name | Risedronate sodium |
| Company Name | AURO PHARMA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | RISEDRONATE SODIUM |
| Strength(s) | 35MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 1x4 |
| ATC code | M05BA |
| ATC description | DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2019-06-21 |
| Estimated end date | |
| Actual end date | 2020-06-05 |
| Shortage status | Resolved |
| Updated date | 2020-06-08 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 3700 STEELES AVENUE WEST, SUITE 402 WOODBRIDGE, ONTARIO CANADA L4L 8K8 |
| Company contact information | Balaji Srinivasan |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v21 | 2020-06-08 | French | Compare |
| v20 | 2020-06-08 | English | Compare |
| v19 | 2020-03-13 | French | Compare |
| v18 | 2020-03-13 | English | Compare |
| v17 | 2019-12-20 | French | Compare |
| v16 | 2019-12-20 | English | Compare |
| v15 | 2019-10-24 | French | Compare |
| v14 | 2019-10-24 | English | Compare |
| v13 | 2019-10-21 | French | Compare |
| v12 | 2019-10-21 | English | Compare |
| v11 | 2019-09-18 | French | Compare |
| v10 | 2019-09-18 | English | Compare |
| v9 | 2019-09-05 | French | Compare |
| v8 | 2019-09-05 | English | Compare |
| v7 | 2019-08-16 | French | Compare |
| v6 | 2019-08-16 | English | Compare |
| v5 | 2019-06-27 | French | Compare |
| v4 | 2019-06-27 | English | Compare |
| v3 | 2019-06-22 | English | Compare |
| v2 | 2019-06-21 | French | Compare |